Healthcare distributor and services company Cardinal Health (NYSE: CAH) will be announcing earnings results this Tuesday before market open. Here’s what to look for.
Cardinal Health missed analysts’ revenue expectations by 1% last quarter, reporting revenues of $54.88 billion, flat year on year. It was a mixed quarter for the company, with a decent beat of analysts’ EPS estimates.
Is Cardinal Health a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Cardinal Health’s revenue to grow 1.5% year on year to $60.75 billion, slowing from the 12.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.03 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Cardinal Health has missed Wall Street’s revenue estimates four times over the last two years.
Looking at Cardinal Health’s peers in the healthcare providers & services segment, some have already reported their Q2 results, giving us a hint as to what we can expect. McKesson delivered year-on-year revenue growth of 23.4%, beating analysts’ expectations by 1.4%, and CVS Health reported revenues up 8.4%, topping estimates by 5.1%. McKesson traded down 5.6% following the results while CVS Health’s stock price was unchanged.
Read our full analysis of McKesson’s results here and CVS Health’s results here.
Questions about potential tariffs and corporate tax changes have caused much volatility in 2025. While some of the healthcare providers & services stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.6% on average over the last month. Cardinal Health is down 2.7% during the same time and is heading into earnings with an average analyst price target of $179.93 (compared to the current share price of $157.40).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
